No Carolina / NY / Florida
Ph: 561.316.3330

LG Reviewed 21-Inch Diagnostic Monitor Amid Full Display Line Showcasedat RSNA 2023

Summation

  • Visitors will easily be able to spot the booth thanks to the giant 136-inch (diagonal) LG direct-view light-emitting diode (DVLED) display demonstrating the power of the large, bright displays to attract attention and provide an excellent canvas for conference room presentations or virtual collaborations in today's state-of-the-art radiological centers and medical complexes.
  • “In addition to the medical devices, our booth also showcases the convenience of LG UltraPC laptops and the eye-catching power of LG All-in-One DVLED displays for conference spaces or public-facing needs, reinforcing the strength of LG's vast product catalog to serve virtually every need.
  • 0 autonomous delivery robot – will also be on display to show the breadth of LG's solutions on offer to assist the functional needs of a hospital environment.

At RSNA 2023, LG Business Solutions USA will unveil an advanced new 21-inch 5MP diagnostic monitor, while showcasing its full line of displays specially designed for radiology, mammography, diagnostics, clinical review and surgical imagery, along with digital X-ray detectors.

According to Stephen K. Hu, LG Business Solutions USA’s head of medical displays, RSNA attendees who visit LG’s booth #1361 can see how its wide variety of medical displays increase flexibility and choice while delivering leading performance and capabilities for various medical settings.

“LG’s expanded family of medical monitors and devices offers hospitals and medical professionals more options to outfit their spaces with precisely the type and size of monitor they need to review medical imagery and make diagnoses,” Hu said. “In addition to the medical devices, our booth also showcases the convenience of LG UltraPC laptops and the eye-catching power of LG All-in-One DVLED displays for conference spaces or public-facing needs, reinforcing the strength of LG’s vast product catalog to serve virtually every need.”

Attendees who visit LG’s booth will be able to learn about 20 unique products, led by the upcoming 21.5-inch 5MP Diagnostic Monitor (model 21HQ613D) which offers a 2048×2560 IPS display, 1800:1 contrast ratio and special features such as an auto luminance sensor and Light Box Mode with external lighting that increases readability in darkened environments. This advanced diagnostic monitor also offers daisy chain capability to connect two monitors to a single PC and includes five hot keys for rapid switching between screen modes.

It’s the perfect addition to LG’s diagnostic display lineup, especially for showcasing Mammographic images. The new monitor will be showcased alongside LG’s flagship display for Mammographic images: the 31HN713D, which provides a solution for side-by-side viewing with a 12MP resolution. As a result, it can accommodate dual 5MP Mammographic images on its 31-inch (3:2) IPS display.

Throughout the booth, attendees can experience the LG difference as they view 4K diagnostic, surgical and clinical review monitors ranging from 21- to 32 inches, along with a 55-inch 4K IPS surgical monitor. Among the products on display is a 24-inch 2MP IPS monitor that is pending FDA 510(K) clearance and is not yet available for commercial sale in the United States.

Buyers will also have the opportunity to see LG’s line of powerful and cost-efficient portable X-ray detectors with oxide and amorphous silicon TFT to ensure clear images, with each of the three model sizes offering up to 300 images per charge.

LG’s 75-inch CreateBoard multi-touch digital whiteboard, Box-Type Thin Client PC, DualUp 16:18 IPS monitors and UltraPC laptops – even the cutting-edge LG CLOi ServeBot 3.0 autonomous delivery robot – will also be on display to show the breadth of LG’s solutions on offer to assist the functional needs of a hospital environment.

Visitors will easily be able to spot the booth thanks to the giant 136-inch (diagonal) LG direct-view light-emitting diode (DVLED) display demonstrating the power of the large, bright displays to attract attention and provide an excellent canvas for conference room presentations or virtual collaborations in today’s state-of-the-art radiological centers and medical complexes.

“LG is fully committed to delivering the highest quality displays and products for diagnostics, detection and medical review needs to help hospitals and medical professionals deliver exceptional care,” Hu said. “As our catalog of specialized devices grows, we will continue to deliver forward-looking solutions based on the constant advances in medical care and providers’ expectations.”

For more information about LG’s medical products that will be on display at RSNA 2023, click here.

More News

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment

The new Roden ADA Kit expedites bioanalysis by removing the need for assay development and optimization across molecules to provide robust, reproducible, reliable data from nanoliter sample volumes. This is beneficial when ADA assessment is evaluated in preclinical animal models where sample volume may be limited.

Unleashing Biotech Potential: ATLATL Scientific & Miltenyi Biotec Partnership

Since the inception of their partnership five years ago, ATLATL Scientific and Miltenyi Biotec have worked closely together to leverage their respective expertise and resources.

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy